Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED95 of Lidocaine 1.0% for Adductor Canal Block
NCT02033356Phase 2Completed
- Sponsor
- Rigshospitalet
- Start
- Jan 2014
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lidocaine, sponsored by Rigshospitalet. Started Jan 2014; status: completed.
02
Drugs
lidocaine
Beyond the preview
Go deeper on NCT02033356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02033356.